Value and growth are not just style labels. They describe different hypotheses about where stock returns come from, and mixing value vs growth equity strategies without understanding the tradeoff often produces results that surprise investors at both ends of the market cycle.
What separates value stocks from growth stocks
A value strategy screens for names that look cheap relative to fundamentals — compressed price-to-earnings, high free cash flow yield, low price-to-book. The thesis is mean reversion: the market has priced in a pessimistic scenario that doesn't materialize, so the stock re-rates upward over time.
A growth strategy screens for names with high revenue expansion or earnings acceleration, often trading at rich multiples. The thesis is compounding: the business earns its way into those multiples, and an early-stage competitive advantage widens into a durable lead.
Both theses are internally coherent. They just carry different risk profiles and respond differently to the same macro environment.
How cycle exposure differs
Value tends to outperform during recoveries, when beaten-down cyclicals lead, and in environments where cheap capital no longer inflates expensive multiples. Growth tends to outperform when rates fall (high-duration assets benefit from lower discount rates) and when large-cap technology commands index flows.
There are prolonged stretches — the 2016-to-2020 period is a well-documented example — where growth compounded at rates that made value investors question the entire framework. There are also quarters, like 2022, where growth strategies gave back years of outperformance in twelve months.
Neither style wins permanently. The relevant question is how much drawdown you can absorb without abandoning the strategy, and over what horizon you're measuring results.
US20 and IT15: a concrete comparison
VelaDeck's AI-curated strategies make the contrast concrete. US20 — Top Value Stocks — runs 20 holdings, rebalances monthly, and has accumulated approximately +145% over five years in historical simulation. Its composition tends toward names with proven cash generation and favorable valuation ratios. It's structured for long-horizon investors.
IT15 — Tech Titans — runs 15 holdings, also rebalances monthly, and has returned approximately +43% over the trailing year in simulation. It carries higher beta than US20. Because it concentrates in technology, it amplifies both the upside in tech rallies and the drawdown in tech corrections. That's the expected behavior of concentrated sector exposure.
These figures are historical simulations only. They don't predict what either strategy will do next year, and they don't capture your specific entry timing, cash drag between signals, or execution costs. Visit the [strategies page](/strategies) for current holdings counts and rebalance cadence.
Blending both: what it changes and what it doesn't
Holding both US20 and IT15 in VelaDeck doesn't average their characteristics — it weights them according to how much capital you assign each. If you allocate $3,000 to US20 and $1,000 to IT15, roughly 75% of your notional tracks the value signal and 25% tracks the growth signal. Each strategy's monthly rebalance fires independently, and VelaDeck sizes the orders against each allocation separately.
A blended allocation lets you express a tilted view — for example, that value outperforms over the next three years but you still want technology exposure — without making a binary bet. It also gives you two independent signal sources, which matters when one strategy has a quiet rebalance month and the other rotates heavily.
What blending does not do is reduce the volatility of either position. IT15's higher beta doesn't diminish because you hold less of it. You remain exposed to tech corrections on the IT15 portion of your allocation.
How to read the blended backtest
VelaDeck's backtest simulator takes your specific allocation across strategies and generates a weighted historical return series. A $3,000 / $1,000 split between US20 and IT15 weights US20's monthly returns at 75% and IT15's at 25%, and shows what that blend would have produced historically.
This is a useful benchmark comparison tool, but it has limits. It doesn't model the lag between when a signal fires and when your order fills, cash drag while you're between signals, or what happens when both strategies drop the same name simultaneously. The backtest tells you how a blend would have behaved in the past — not what it will do going forward.
For a walkthrough of validating signals before committing real capital, see the [paper to live trading guide](/blog/paper-to-live-trading-safely).
Practical criteria for choosing between styles
There's no universally correct answer. A few variables that sharpen the decision:
- **Time horizon.** US20's five-year simulation record is more relevant to multi-year holding periods. IT15's one-year figure matters more if you're focused on near-term momentum. Shorter horizons with high-beta strategies increase sequence-of-returns risk.
- **Volatility tolerance.** Higher-beta strategies produce larger drawdowns. If a 20% portfolio drop in a quarter would prompt you to stop the automation, a concentrated growth strategy isn't the right fit regardless of its simulation history.
- **Portfolio context.** If your other accounts are already heavy in technology — a common situation for investors in cap-weighted index funds after 2020 — adding IT15 concentrates an existing tilt further. US20 may diversify your total picture more meaningfully.
- **Rebalance activity.** Both US20 and IT15 rebalance monthly. If you prefer fewer signals and lower turnover, WB15 — Best of Buffett — rebalances quarterly with historically lower churn.
VelaDeck does not provide investment advice, and nothing here is a recommendation. These are variables to weigh based on your own situation and risk tolerance.
Frequently asked questions
Can I run US20 and IT15 simultaneously in VelaDeck?
Yes. You assign a USD notional to each strategy independently. VelaDeck processes each strategy's rebalance separately and generates orders sized against each allocation. Visit the [strategies page](/strategies) to see current holdings and set up allocations.
Does blending a value and growth strategy reduce overall portfolio risk?
Not directly. Blending changes the weight of each signal's impact on your total notional, but each strategy still carries its own exposure. IT15's higher beta doesn't drop because you hold a smaller allocation to it. The correlation between the two strategies also varies — in a broad market selloff, both tend to fall together.
Are the historical performance figures guaranteed?
No. The figures — approximately +145% over five years for US20, approximately +43% over the trailing year for IT15 — are historical simulations. Past performance is not a forecast of future returns. Market conditions change, and simulation figures don't capture real-world details like your specific fill prices or the timing of your capital deployment.
Does VelaDeck hold my money?
No. VelaDeck connects to your own Alpaca brokerage account via OAuth. Your capital stays in your account at all times. VelaDeck submits orders on your behalf only after you explicitly opt into live trading in Settings. Paper mode is the default — nothing goes live until you flip that switch. [Create an account to start with paper trading first.](/signup)
What happens if both US20 and IT15 drop the same name in the same rebalance?
Each strategy's SELL signal is handled independently against its own allocation. If both strategies remove the same ticker, you'll see two separate SELL orders — one sized against your US20 notional and one against your IT15 notional. VelaDeck uses your actual position quantity per order, so it never over-sells across the combined position.